KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Invested Capital (2016 - 2025)

Historic Invested Capital for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $836.6 million.

  • Neogenomics' Invested Capital fell 728.96% to $836.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $836.6 million, marking a year-over-year decrease of 728.96%. This contributed to the annual value of $836.6 million for FY2025, which is 728.96% down from last year.
  • Neogenomics' Invested Capital amounted to $836.6 million in Q4 2025, which was down 728.96% from $838.3 million recorded in Q3 2025.
  • In the past 5 years, Neogenomics' Invested Capital ranged from a high of $1.1 billion in Q2 2021 and a low of $836.6 million during Q4 2025
  • Over the past 5 years, Neogenomics' median Invested Capital value was $944.5 million (recorded in 2023), while the average stood at $962.7 million.
  • Per our database at Business Quant, Neogenomics' Invested Capital soared by 4031.66% in 2021 and then crashed by 1092.61% in 2022.
  • Quarter analysis of 5 years shows Neogenomics' Invested Capital stood at $1.1 billion in 2021, then decreased by 9.95% to $998.0 million in 2022, then decreased by 5.66% to $941.5 million in 2023, then dropped by 4.16% to $902.3 million in 2024, then decreased by 7.29% to $836.6 million in 2025.
  • Its last three reported values are $836.6 million in Q4 2025, $838.3 million for Q3 2025, and $854.0 million during Q2 2025.